Evercare, part of what was formerly the Abraaj Growth Markets Health Fund (AGHF) and now managed by global PE firm TPG, has appointed a new CEO to oversee its hospitals and clinics in India, Pakistan, Kenya and Nigeria.
Ten months after entrepreneur Joseph Priel unexpectedly died, HBI understands that Edna Priel, his wife, has started to be increasingly hands on with the management of the family's assets and investments in Croatia, Hungary and Romania.
Conglomerate-owned Italian hospital group Humanitas is in the process to buy Romanian healthcare group Regina Maria. HBI understands Mid Europa tried to sell the company before summer without success, possibly because of the price.
London-listed investment firm ICG is reportedly selling its UK-Australia teleradiology platform Everlight Radiology, while a Spanish diagnostics group recently entered the Latin American market with a small deal. The deals show two of the four cross-border teleradiology streams we have identified.
BR Salud, the Spanish JV owned by Unilabs and Ribera Salud, has lost its multi-million euro public contract to the country's fourth-largest lab group Analiza. It was worth, HBI estimates, 15-20% of Unilabs' Spain revenue.
Russian publicly-traded investor Sistema and its healthcare network Medsi is in talks with Russia’s largest insurance private company AlfaStrakhovanie to buy 100% of its Alfa Health Center clinics, according to the Russian press.
Global private equity firm KKR and Singaporean sovereign wealth fund GIC have agreed to co-invest nearly $700m in Filipino hospital group Metro Pacific Hospital Holdings Inc (MPHHI) as well as a bond issued by majority-owner conglomerate MPIC, pulling the plug on any immediate IPO. The Philippines is the last major SE Asian market to see big PE money enter its healthcare sector.
Two years after Dubai Health Authority (DHA) issued an order regulating telehealth, the department has finally cleared up rules around what the doctor is allowed to do in a doctor-patient teleconsultation. HBI examines how the new regulations will change the market and how they compare to elsewhere in the world.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.